Seladelpar Completed Phase 2 Trials for Hyperlipidemias Treatment

Back to Seladelpar
IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00701883
Safety and Benefit of MBX-8025 With and Without Commonly Used Statins in Moderately Overweight Patients With High Cholesterol